When does depression become a disorder? Using recurrence rates to evaluate the validity of proposed changes in major depression diagnostic thresholds

World Psychiatry

Volumn 12, Issue 1, 2013, Pages 44-52

  Wakefield, Jerome C ^a,b,c,d   Schmitz, Mark F ^c,e  

^a NEW YORK UNIVERSITY   (United States)

^b NEW YORK UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c NEW YORK UNIVERSITY   (United States)

^d NONE   (United States)

^e TEMPLE UNIVERSITY   (United States)

Author keywords

Diagnosis; Major depression; Melancholic depression; Recurrence; Severity; Uncomplicated depression; Validity

Indexed keywords

ADULT; AGED; ARTICLE; CHRONICITY; CONTROLLED STUDY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MAJOR DEPRESSION; MALE; PREDICTIVE VALIDITY; PRIORITY JOURNAL; PSYCHOMOTOR RETARDATION; PSYCHOSIS; RECURRENCE RISK; RECURRENT DISEASE; SUICIDAL IDEATION;

EID: 84877698004     PISSN: 17238617     EISSN: 20515545     Source Type: Journal    
DOI: 10.1002/wps.20015     Document Type: Article

References (55)

1. Clayton P, Desmarais L, Winokur G. A study of normal bereavement. Am J Psychiatry 1968;125:168-78.
2. Regier DA, Kaelber CT, Rae DS et al. Limitations of diagnostic criteria and assessment instruments for mental disorders: implications for research and policy. Arch Gen Psychiatry 1998;55:109-15.
3. Kendler KS, Munoz RA, Murphy G. The development of the Feigh-ner criteria: a historical perspective. Am J Psychiatry 2010;167:134-42.
4. Kendler KS, Gardner CO. Boundaries of major depression: an evaluation of DSM-IV criteria. Am J Psychiatry 1998;155:172-7.
5. Kessler RC, Zhao SY, Blazer DG et al. Prevalence, correlates, and course of minor depression and major depression in the National Comorbidity Survey. J Affect Disord 1997;45:19-30.
6. Klein DF, Thase M. Medication versus psychotherapy for depression: progress notes. Am Soc Clin Psychopharmacol 1997;8:41-7.
7. Eaton WW, Anthony JC, Gallo J et al. Natural history of Diagnostic Interview Schedule/DSM-IV major depression: the Baltimore Epidemiologic Catchment Area follow-up. Arch Gen Psychiatry 1997;54:993-9.
8. Eaton WW, Neufeld K, Chen LS et al. A comparison of self-report and clinical diagnostic interviews for depression: Diagnostic Interview Schedule and Schedules for Clinical Assessment in Neuropsychiatry in the Baltimore Epidemiologic Catchment Area follow-up. Arch Gen Psychiatry 2000;57:217-22.
9. Moffitt TE, Caspi A, Taylor A et al. How common are common mental disorders? Evidence that lifetime prevalence rates are doubled by prospective versus retrospective ascertainment. Psy-chol Med 2010;40:899-909.
10. Tyrer P. Are general practitioners really unable to diagnose depression? Lancet 2009;374:589-90.
11. Fink M, Taylor MA. Resurrecting melancholia. Acta Psychiatr Scand 2007;115(Suppl. 433):14-20.
12. Goldberg D. The heterogeneity of "major depression". World Psychiatry 2011;10:226-8.
13. Maj M. When does depression become a mental disorder? Br J Psychiatry 2011;199:85-6.
14. Maj M. Refining the diagnostic criteria for major depression on the basis of empirical evidence. Acta Psychiatr Scand 2011;123:317.
15. American Psychiatric Association. Diagnostic and statistical manual of mental disorders: DSM-IV-TR, 4th ed. Washington: American Psychiatric Association, 2000.
16. Burcusa SL, Iacono WG. Risk for recurrence in depression. Clin Psychol Rev 2007;27:959-85.
17. Colman I, Naicker K, Zeng Y et al. Predictors of long-term prognosis of depression. Can Med Assoc J 2011;183:1969-76.
18. Coryell W, Endicott J, Keller MB. Predictors of relapse into major depressive disorder in a nonclinical population. Am J Psychiatry 1991;148:1353-8.
19. Judd LL, Akiskal HS, Maser JD et al. A prospective 12-year study of subsyndromal and syndromal depressive symptoms in unipolar major depressive disorders. Arch Gen Psychiatry 1998;55:694-700.
20. Monroe SM, Harkness KL. Recurrence in major depression: a conceptual analysis. Psychol Rev 2011;118:655-74.
21. Mueller TI, Leon AC, Keller MB et al. Recurrence after recovery from major depressive disorder during 15 years of observational follow-up. Am J Psychiatry 1999;156:1000-6.
22. Zisook S, Shear K, Kendler KS. Validity of the bereavement exclusion criterion for the diagnosis of major depressive disorder. World Psychiatry 2007;6:102-7.
23. Mojtabai R. Bereavement-related depressive episodes: characteristics, 3-year course, and implications for DSM-5. Arch Gen Psychiatry 2011;68:920-8.
24. Greden JF. The burden of recurrent depression: causes, consequences, and future prospects. J Clin Psychiatry 2001;62(Suppl. 22):5-9.
25. Nierenberg AA, Petersen TJ, Alpert JE. Prevention of relapse and recurrence in depression: the role of long-term pharmacotherapy and psychotherapy. J Clin Psychiatry 2003;64(Suppl. 15):13-7.
26. Solomon DA, Keller MB, Leon AC et al. Multiple recurrences of major depressive disorder. Am J Psychiatry 2000;157:229-33.
27. Bockting CLH, ten Doesschate MC, Spijker J et al. Continuation and maintenance use of antidepressants in recurrent depression. Psychother Psychosom 2008;77:17-26.
28. Clarke GN, Rohde P, Lewinsohn PM. Cognitive-behavioral treatment of adolescent depression: efficacy of acute group treatment and booster sessions. J Am Acad Child Adolesc Psychiatry 1999;38:272-9.
29. Geddes JR., Carney SM, Davies C et al. Relapse prevention with antidepressant drug treatment in depressive disorders: a systematic review. Lancet 2003;361:653-61.
30. Frank E, Prien RF, Jarrett RB et al. Conceptualization and rationale for consensus definitions of terms in major depressive disorder: remission, recovery, relapse, and recurrence. Arch Gen Psychiatry 1991;48:851-5.
31. Wakefield JC, Schmitz MF. Recurrence of depression after bereavement-related depression: evidence for the validity of DSM-IV bereavement exclusion from the Epidemiologic Catchment Area Study. J Nerv Ment Dis 2012;200:480-5.
32. Robins LN, Regier DA. Psychiatric disorders in America. New York: Free Press, 1991.
33. American Psychiatric Association. Diagnostic and statistical manual of mental disorders, 3rd ed. Washington: American Psychiatric Association, 1980.
34. Spitzer RL, Wakefield JC. DSM-IV diagnostic criterion for clinical significance: does it help solve the false positives problem? Am J Psychiatry 1999;156:1856-64.
35. Wakefield JC, Schmitz MF, Baer JC. Does the DSM-IV clinical significance criterion for major depression reduce false positives? Evidence from the NCS-R. Am J Psychiatry 2010;167:298-304.
36. Zimmerman M, Chelminski I, Young D. On the threshold of disorder: a study of the impact of the DSM-IV clinical significance criterion on diagnosing depressive and anxiety disorders in clinical practice. J Clin Psychiatry 2004;65:1400-5.
37. Barkow K, Maier W, Ustun B et al. Risk factors for depression at 12-month follow-up in adult primary health care patients with major depression: an international prospective study. J Affect Dis-ord 2003;76:157-69.
38. Maj M. Bereavement related depression in the DSM-5 and ICD-11. World Psychiatry 2012;11:1-2.
39. Wakefield JC, First MB. Validity of the bereavement exclusion to major depression: does the empirical evidence support the proposal to eliminate the exclusion in DSM-5? World Psychiatry 2012;11:11-5.
40. Wakefield JC, Schmitz MF, First MB et al. Should the bereavement exclusion for major depression be extended to other losses? Evidence from the National Comorbidity Survey. Arch Gen Psychiatry 2007;64:433-40.
41. Chouinard G, Chouinard VA, Corruble E. Beyond DSM-IV bereavement exclusion criterion E for major depressive disorder. Psychother Psychosom 2011;80:4-9.
42. Parker G. Classifying clinical depression: an operational proposal. Acta Psychiatr Scand 2011;123:314-6.
43. Broadhead WE, Blazer DG, George LK et al. Depression, disability days, and days lost from work in a prospective epidemiologic survey. JAMA 1990;264:2524-8.
44. Elkin I, Shea T, Watkins JT et al. National Institute of Mental Health Treatment of Depression Collaborative Research Program: general effectiveness of treatments. Arch Gen Psychiatry 1989;46:971-82.
45. Shorter E. The doctrine of the two depressions in historical perspective. Acta Psychiatr Scand 2007;115:5-13.
46. Wakefield JC, Schmitz MF, Baer JC. Did narrowing the major depression bereavement exclusion from DSM-III-R to DSM-IV increase validity? Evidence from the National Comorbidity Survey. J Nerv Ment Dis 2011;199:66-73.
47. Wakefield JC, Schmitz MF, Baer JC. Relation between duration and severity in bereavement-related depression. Acta Psychiatr Scand 2011;124:487-94.
48. Stata Corporation. Stata statistical software, Release 12 (Version 12). Texas: Stata Corporation, 2011.
49. Kendler KS, Myers J, Zisook S. Does bereavement-related major depression differ from major depression associated with other stressful life events? Am J Psychiatry 2008;165:1449-55.
50. Zisook S, Kendler KS. Is bereavement-related depression different than nonbereavement-related depression? Psychol Med 2007;37:779-94.
51. Narrow WE, Rae DS, Robins LN et al. Revised prevalence estimates of mental disorders in the United States: using a clinical significance criterion to reconcile 2 survey's estimates. Arch Gen Psychiatry 2002;59:115-23.
52. Beals J, Novins DK, Spicer P et al. Challenges in operationalizing the DSM-IV clinical significance criterion. Arch Gen Psychiatry 2004;61:1197-207.
53. Ustun B, Kennedy C. What is "functional impairment"? Disentangling disability from clinical significance. World Psychiatry 2009;8:82-5.
54. Wakefield JC. Disability and diagnosis: should role impairment be eliminated from DSM/ICD diagnostic criteria? World Psychiatry 2009;8:87-8.
55. Wakefield JC, Spitzer RL. Lowered estimates-but of what? Arch Gen Psychiatry 2002;59:129-30.